IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 306 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $68,040 | +10.6% | 1,500 | 0.0% | 0.05% | +13.6% |
| Q2 2023 | $61,545 | +14.8% | 1,500 | 0.0% | 0.04% | +10.0% |
| Q1 2023 | $53,610 | -5.4% | 1,500 | 0.0% | 0.04% | -9.1% |
| Q4 2022 | $56,655 | -14.2% | 1,500 | 0.0% | 0.04% | -17.0% |
| Q3 2022 | $66,000 | +17.9% | 1,500 | 0.0% | 0.05% | +65.6% |
| Q1 2022 | $56,000 | +21.7% | 1,500 | 0.0% | 0.03% | +28.0% |
| Q4 2021 | $46,000 | -8.0% | 1,500 | 0.0% | 0.02% | -13.8% |
| Q3 2021 | $50,000 | -16.7% | 1,500 | 0.0% | 0.03% | -12.1% |
| Q2 2021 | $60,000 | -10.4% | 1,500 | 0.0% | 0.03% | -19.5% |
| Q1 2021 | $67,000 | – | 1,500 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,541,136 | $133,749 | 7.12% |
| Bellevue Group AG | 9,743,900 | $368,027,103 | 4.88% |
| M28 Capital Management LP | 126,300 | $4,770,351 | 4.55% |
| Sicart Associates LLC | 246,258 | $9,301,165 | 3.28% |
| Camber Capital Management LP | 1,925,000 | $72,707 | 2.49% |
| Privium Fund Management B.V. | 148,807 | $5,557,941 | 2.11% |
| Deep Track Capital, LP | 1,205,773 | $45,542,046 | 1.91% |
| BVF INC/IL | 1,121,809 | $42,370,726 | 1.79% |
| Orbimed Advisors | 1,993,600 | $75,298,272 | 1.44% |
| Parkman Healthcare Partners LLC | 141,115 | $5,329,914 | 1.42% |